<tbody id="grid1_body_tbody"><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_0_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="0" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_0_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="1" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>세경하이테크(148150)</nobr></td><td datatype="" displayformat="" id="grid1_cell_0_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="2" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>세경하이테크-탐방노트: 다시 한번 성장주로 인식될 시점<br>ㅁ 중국 스마트폰 시장 회복 수혜<br>ㅁ OCA(투명접착필름) 북미 태블릿 신규 진입<br>ㅁ 2차전지 신사업 시작</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_0_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="3" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="4" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="5" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>17,590</nobr></td><td datatype="text" displayformat="" id="grid1_cell_0_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="6" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>메리츠증권</nobr></td><td id="grid1_cell_0_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="7" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>양승수</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_1_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="8" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_1_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="9" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대오토에버(307950)</nobr></td><td datatype="" displayformat="" id="grid1_cell_1_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="10" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대오토에버-이제 막 시작<br>ㅁ 장기적 관점 투자 매력적<br>ㅁ SI 업체로서 높은 밸류에이션은 가이던스에 따른 성장만으로도 충분히 정당화되며 보수적인 가이던스 제시 경향 고려 시 가이던스 상향도 기대 가능<br>ㅁ 다만 그 가능성을 실적으로 확인하는 시점은 2H24로 전망</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_1_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="11" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="12" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>210,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="13" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>172,700</nobr></td><td datatype="text" displayformat="" id="grid1_cell_1_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="14" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_1_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="15" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김하정</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_2_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="16" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_2_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="17" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>일진하이솔루스(271940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_2_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="18" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>일진하이솔루스-상용 시장 확대 준비 착착<br>ㅁ 수소연료전지차 판매 둔화에 따른 영향<br>ㅁ 상용 차량 증가 수혜 본격화</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_2_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="19" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="20" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>38,600</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="21" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>23,950</nobr></td><td datatype="text" displayformat="" id="grid1_cell_2_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="22" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>SK증권</nobr></td><td id="grid1_cell_2_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="23" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>나승두</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_3_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="24" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_3_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="25" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>펄어비스(263750)</nobr></td><td datatype="" displayformat="" id="grid1_cell_3_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="26" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>펄어비스-진실된 퍼즐이 맞춰질 필요<br>ㅁ 게임 업종 Top pick 유지<br>ㅁ 매니지먼트의 투자자들에게 대한 케어가 요구</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_3_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="27" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="28" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>75,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="29" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>40,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_3_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="30" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>키움증권</nobr></td><td id="grid1_cell_3_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="31" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김진구</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_4_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="32" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_4_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="33" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블(251270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_4_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="34" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>넷마블-이 중에 취향인 게임 한 개쯤은 있겠지<br>ㅁ 2024년 신작 최소 9종 예정<br>ㅁ 명작 IP 활용의 좋은예</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_4_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="35" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="36" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="37" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>55,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_4_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="38" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>흥국증권</nobr></td><td id="grid1_cell_4_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="39" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김지현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_5_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="40" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_5_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="41" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성바이오로직스(207940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_5_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="42" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성바이오로직스-ADC 생산 기술력 확보는 필수적<br>ㅁ ADC 신공정 건설계획에 따라 2024 년 상업생산 들어간다, 글로벌 ADC 수요 대응<br>ㅁ 론자, 우시, 롯데바이오로직스도 마찬가지로 ADC 사업 본격화, 글로벌 선두 기업들의 미래 방향</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_5_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="43" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="44" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>1,000,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="45" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>709,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_5_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="46" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_5_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="47" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엄민용</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_6_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="48" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_6_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="49" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠(196170)</nobr></td><td datatype="" displayformat="" id="grid1_cell_6_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="50" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠-피하주사 나비효과<br>ㅁ 유럽서 피하주사 변경 시 환자, 의료진, 보험사의 시간적, 비용적 절감 -60% 이상 실사례 확인<br>ㅁ 면역항암제 ADC 병용은 효과는 높으나 ADC 부작용 여전히 높지만 SC 적용 시 극복 가능할 것<br>ㅁ 키트루다를 포함한 TOP3 면역항암제 SC 전환이 불러올 나비효과, ADC SC</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_6_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="51" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="52" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="53" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>74,100</nobr></td><td datatype="text" displayformat="" id="grid1_cell_6_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="54" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_6_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="55" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엄민용</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_7_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="56" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_7_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="57" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엘아이지넥스원(079550)</nobr></td><td datatype="" displayformat="" id="grid1_cell_7_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="58" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>LIG넥스원-10년 전 과거에서 찾은 힌트<br>ㅁ ‘14년과 유사하게 유럽-중동-동남아 순으로 대립 점화 중. 단기/중장기 미사일 수출사업 확대 예상<br>ㅁ ‘24년 사우디 천궁-II에 이어 말레이시아, 루마니아 수출 및 비궁 미국 방산시장 진출 기대<br>ㅁ 개발사업 비중 증가</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_7_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="59" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="60" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>130,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="61" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>91,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_7_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="62" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_7_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="63" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동호</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_8_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="64" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_8_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="65" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대로템(064350)</nobr></td><td datatype="" displayformat="" id="grid1_cell_8_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="66" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대로템-더 이상 나빠질 게 없다<br>ㅁ ‘24~‘25년 폴란드 1차 사업 K2PL 전차 납품 본격화로 방산 부문 고성장 전망<br>ㅁ 폴란드 2차 사업 최종계약 시 ‘27년까지 증익 명확해지며 중장기 모멘텀이 될 것으로 예상<br>ㅁ 폴란드 2차 계약 지연 또는 규모 축소</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_8_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="67" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="68" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>37,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="69" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>25,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_8_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="70" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_8_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="71" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동호</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_9_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="72" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_9_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="73" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한미약품(128940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_9_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="74" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HanmiPharm-Rolling out a new obesity pipeline<br>ㅁ A new obesity pipeline at the center of mid/long-term strategy<br>ㅁ Clinical data for MASH pipeline to be announced in 2024<br>ㅁ TP slightly lowered to KRW400,000, hopes for GLP-1 CMO deals</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_9_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="75" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="76" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>400,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="77" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>303,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_9_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="78" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Shinhan Investment &amp;</nobr></td><td id="grid1_cell_9_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="79" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정재원</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_10_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="80" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_10_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="81" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한미약품(128940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_10_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="82" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한미약품-비만에 진심인 편<br>ㅁ 회사의 중장기 방향성은 비만 전주기 맞춤형 포트폴리오 구축 <br>ㅁ 24년 MASH(이전 NASH) 파이프라인 임상 데이터 발표 전망 <br>ㅁ 목표주가 소폭 하향(기존 41.5만원). GLP-1 CMO 가능성 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_10_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="83" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="84" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>400,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="85" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>303,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_10_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="86" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_10_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="87" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정재원</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_11_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="88" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_11_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="89" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국항공우주산업(047810)</nobr></td><td datatype="" displayformat="" id="grid1_cell_11_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="90" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국항공우주-결실을 맺을 2024년<br>ㅁ ‘24~‘25년 해외 수주 모멘텀 다수 포진. FA-50 우즈벡, 필리핀 등 추가 수주계약 기대<br>ㅁ 남중국해 재점화 조짐. 중동/동남아 군비증강으로 고정익/회전익 수출 가능성 확대 전망<br>ㅁ 기체부품 사업부 실적 부진</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_11_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="91" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="92" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>76,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="93" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>46,650</nobr></td><td datatype="text" displayformat="" id="grid1_cell_11_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="94" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_11_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="95" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동호</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_12_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="96" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_12_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="97" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>셀트리온헬스케어(091990)</nobr></td><td datatype="" displayformat="" id="grid1_cell_12_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="98" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Celltrion Healthcare-A beautiful farewell<br>ㅁ 3Q23 review: Weak 1H, strong 2H earnings confirmed<br>ㅁ Switch to direct sales humming along<br>ㅁ Retain BUY rating and target price of KRW90,000</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_12_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="99" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="100" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>90,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="101" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>73,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_12_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="102" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Shinhan Investment &amp;</nobr></td><td id="grid1_cell_12_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="103" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정재원</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_13_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="104" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_13_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="105" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>셀트리온헬스케어(091990)</nobr></td><td datatype="" displayformat="" id="grid1_cell_13_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="106" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>셀트리온헬스케어-아름다운 이별<br>ㅁ 3Q23 Re; 상저하고 흐름 증명 <br>ㅁ 직판 체제로의 전환을 위한 준비는 순조롭게 진행 중 <br>ㅁ 목표주가 유지. 아름다운 이별의 시간을 맞이할 때</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_13_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="107" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="108" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>90,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="109" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>73,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_13_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="110" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_13_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="111" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정재원</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_14_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="112" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_14_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="113" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>셀트리온(068270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_14_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="114" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>셀트리온-세 회사와 시너지, ADC 신약개발 집중<br>ㅁ 익수다와 레고켐바이오, 피노바이오, 3 개 회사와 ADC 파이프라인 개발 중<br>ㅁ 피노바이오와 기술이전 계약을 살펴보면 ADC 기술에 대한 다양한 투자 진행 중</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_14_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="115" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="116" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>210,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="117" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>168,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_14_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="118" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_14_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="119" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엄민용</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_15_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="120" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_15_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="121" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>KH바텍(060720)</nobr></td><td datatype="" displayformat="" id="grid1_cell_15_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="122" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>KH바텍-폴더블 힌지, 매출 다변화가 필요<br>ㅁ 3Q23 폴더블 판매량 부진 아쉬움, 판가 상승 효과로 만회<br>ㅁ 폴더블 힌지, 매출 다변화가 필요<br>ㅁ 티타늄, 힌지 사업 리스크를 방어할 동아줄</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_15_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="123" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="124" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>22,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="125" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>14,370</nobr></td><td datatype="text" displayformat="" id="grid1_cell_15_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="126" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이베스트투자증권</nobr></td><td id="grid1_cell_15_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="127" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김광수</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_16_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="128" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_16_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="129" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼보모터스(053700)</nobr></td><td datatype="" displayformat="" id="grid1_cell_16_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="130" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼보모터스-전기차용 부품군으로 확장<br>ㅁ 2023년 실적호조 달성<br>ㅁ 2024년부터 전기차용 부품의 공급 시작<br>ㅁ 전환사채 희석을 감안한 P/E 5배 초반</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_16_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="131" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="132" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="133" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>5,730</nobr></td><td datatype="text" displayformat="" id="grid1_cell_16_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="134" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_16_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="135" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>송선재.안도현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_17_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="136" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_17_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="137" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>케이티스카이라이프(053210)</nobr></td><td datatype="" displayformat="" id="grid1_cell_17_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="138" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>스카이라이프-상철아, 여 접시 아이고 콘텐츠다 ~<br>ㅁ 과거 유료 방송 사업자에서 이제는 콘텐츠 회사로<br>ㅁ 4Q23에는 비용 털고 간다<br>ㅁ 투자의견 BUY, TP 7,500원으로 커버리지 개시</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_17_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="139" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="140" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>7,500</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="141" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>6,080</nobr></td><td datatype="text" displayformat="" id="grid1_cell_17_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="142" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>DB금융투자</nobr></td><td id="grid1_cell_17_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="143" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신은정</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_18_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="144" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_18_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="145" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스지씨이테크건설(016250)</nobr></td><td datatype="" displayformat="" id="grid1_cell_18_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="146" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>SGC이테크건설-수주잔고 소진으로 성장모멘텀 약화<br>ㅁ 3분기 실적: 플랜트 공정 가속화로 매출 급증, 하지만 원가부담은 여전 <br>ㅁ 공정 진행속도를 못 따라가는 신규수주→ 당분간 역성장 불가피할 듯 <br>ㅁ 투자의견 보유로 하향, 목표주가는 22,000원 제시</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_18_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="147" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>보유</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="148" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>22,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="149" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>19,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_18_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="150" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BNK투자증권</nobr></td><td id="grid1_cell_18_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="151" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이선일</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_19_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="152" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_19_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="153" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국가스공사(036460)</nobr></td><td datatype="" displayformat="" id="grid1_cell_19_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="154" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국가스공사-에너지 가격 안정화가 긍정적<br>ㅁ 3Q23 실적은 재무구조 악화 및 1회성 요인으로 세전이익 부진<br>ㅁ 계절적 Spot 가스 가격 변동성 높을 수 있지만, 유가에 연동하는 가스 가격은 1H24까지 하락<br>ㅁ 미수금 증가 속도 정점을 지나고 있다는 판단. 재무구조 악화는 점점 완화될 것</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_19_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="155" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="156" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>35,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="157" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>24,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_19_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="158" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_19_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="159" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>강동진</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_20_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="160" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_20_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="161" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한국단자공업(025540)</nobr></td><td datatype="" displayformat="" id="grid1_cell_20_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="162" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>KorElecTerm-Global expansion and EV trend positive<br>ㅁ Korea Electric Terminal (KET) is an automotive connector company that derives 70% of its sales from Hyundai Motor Group<br>ㅁ Investment point 1. Sales growth and profitability recovery</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_20_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="163" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="164" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="165" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>74,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_20_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="166" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_20_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="167" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>임은영.강희진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_21_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="168" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_21_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="169" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대모비스(012330)</nobr></td><td datatype="" displayformat="" id="grid1_cell_21_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="170" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대모비스-우려보다 기대가 더 크다<br>ㅁ 1) 물류비, 2) 논캡티브 수주, 3) 셀 가격 하락, 4) 주주환원정책 긍정적<br>ㅁ BEV 수요 우려 지속되고 있으나, xEV 믹스 감안 시 영향 제한적<br>ㅁ 4Q23 수익성 견조한 가운데, 일회성 인건비 약 750억 반영 예정</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_21_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="171" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="172" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>310,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="173" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>232,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_21_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="174" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_21_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="175" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김귀연</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_22_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="176" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_22_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="177" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>녹십자(006280)</nobr></td><td datatype="" displayformat="" id="grid1_cell_22_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="178" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>GC Corp-IVIG-SN 10% to be approved soon<br>ㅁ US approval of IVIG-SN 10%<br>ㅁ Some concerns exist but nothing big<br>ㅁ Maintain BUY and raise target to KRW140,000</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_22_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="179" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="180" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>140,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="181" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_22_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="182" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_22_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="183" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서근희</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_23_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="184" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_23_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="185" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>녹십자(006280)</nobr></td><td datatype="" displayformat="" id="grid1_cell_23_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="186" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>녹십자-IVIG-SN 10% 승인 임박<br>ㅁ IVIG-SN 10%의 미국 허가가 의미하는 것<br>ㅁ 약간의 우려는 있으나 극복 가능</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_23_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="187" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="188" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>140,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="189" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>117,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_23_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="190" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_23_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="191" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서근희</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_24_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="192" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_24_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="193" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스엘(005850)</nobr></td><td datatype="" displayformat="" id="grid1_cell_24_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="194" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>SLCORP-2024 outlook: Joining the SDV wave<br>ㅁ Orders ballooning<br>ㅁ 3Q results confirm earnings stability</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_24_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="195" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="196" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>50,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="197" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>33,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_24_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="198" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_24_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="199" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>임은영.강희진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_25_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="200" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_25_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="201" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스엘(005850)</nobr></td><td datatype="" displayformat="" id="grid1_cell_25_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="202" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에스엘-2024년 전망: LED 램프에 이어 SDV 물결에 합류하다<br>ㅁ 커지는 수주 단위<br>ㅁ 3분기에 실적 안정성 확인</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_25_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="203" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="204" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>50,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="205" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>33,250</nobr></td><td datatype="text" displayformat="" id="grid1_cell_25_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="206" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_25_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="207" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>임은영.강희진</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_26_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="208" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_26_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="209" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한화에어로스페이스(012450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_26_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="210" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한화에어로스페이스-아무도 막을 수 없는 성장세<br>ㅁ ‘24~‘25년 폴란드향 K9/천무 납품 일정 집중에 따라 본격적인 증익 구간 진입 전망<br>ㅁ 루마니아 K9/레드백 수주 모멘텀 존재. 이르면 ‘23년말, 늦어도 ‘24년 상반기 사업자 선정<br>ㅁ 정밀기계 사업부 실적 부진</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_26_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="211" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="212" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>150,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="213" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>120,100</nobr></td><td datatype="text" displayformat="" id="grid1_cell_26_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="214" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_26_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="215" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동호</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_27_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="216" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_27_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="217" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>씨제이(001040)</nobr></td><td datatype="" displayformat="" id="grid1_cell_27_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="218" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>CJ-주요 자회사들의 이익 성장세<br>ㅁ 3Q23 Review : 주요 상장 자회사 견조한 실적 개선세<br>ㅁ 멀티숍 1위 올리브영의 추세적 성장세는 지속</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_27_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="219" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="220" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>120,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="221" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>89,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_27_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="222" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>흥국증권</nobr></td><td id="grid1_cell_27_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="223" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>황성진</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_28_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="224" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/24</nobr></td><td datatype="text" id="grid1_cell_28_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="225" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>씨제이대한통운(000120)</nobr></td><td datatype="" displayformat="" id="grid1_cell_28_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="226" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>CJ대한통운-택배 성장 추세로 복귀 전망<br>ㅁ 소비 파편화와 해외 직구의 일상화가 가져올 택배의 새로운 성장 기회<br>ㅁ 코퍼레잇데이 행사를 통해 시장의 해외 직구 물량에 대한 관심을 확인</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_28_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="227" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="228" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>120,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="229" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>95,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_28_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="230" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_28_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="231" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>양지환.이지니</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_29_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="232" or_wd="100" or_bgcolor=""><nobr>2023/11/23</nobr></td><td datatype="text" id="grid1_cell_29_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="233" or_wd="140" or_bgcolor=""><nobr>유한양행(000100)</nobr></td><td datatype="" displayformat="" id="grid1_cell_29_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="234" or_wd="100" or_bgcolor=""><nobr>유한양행-렉라자 국내 1차 급여 효과와 lazer+ami FDA 1차 허가에 주목<br>ㅁ EGFR 비소세포폐암 1차 치료, 타그리소 독점 시장의 유일한 경쟁자, amivantamab+lazertinib MARIPOSA 데이터 기반 lazer+ami의 FDA 허가 신청, 허가 예상<br>ㅁ FDA의 Priority Review→3Q24 허가, Standard Review→4Q24 허가 예상<br>ㅁ Lazer+ami 의 허가 신청 지연, 상업화 지연</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_29_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="235" or_wd="100" or_bgcolor=""><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="236" or_wd="80" or_bgcolor=""><nobr>85,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="237" or_wd="80" or_bgcolor=""><nobr>62,400</nobr></td><td datatype="text" displayformat="" id="grid1_cell_29_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="238" or_wd="100" or_bgcolor=""><nobr>미래에셋증권</nobr></td><td id="grid1_cell_29_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="239" or_wd="50" or_bgcolor=""><nobr>김승민</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255); display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_30_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="240" or_wd="100" style_bak="text-align:center;height:20px" or_bgcolor=""></td><td datatype="text" id="grid1_cell_30_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="241" or_wd="140" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="" displayformat="" id="grid1_cell_30_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="242" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatyp="text" displayformat="" id="grid1_cell_30_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="243" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="244" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="245" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="text" displayformat="" id="grid1_cell_30_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="246" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td id="grid1_cell_30_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="247" or_wd="50" style_bak="text-align:left;height:20px" or_bgcolor=""></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_31_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="248" or_wd="100"></td><td datatype="text" id="grid1_cell_31_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="249" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_31_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="250" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_31_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="251" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="252" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="253" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_31_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="254" or_wd="100"></td><td id="grid1_cell_31_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="255" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_32_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="256" or_wd="100"></td><td datatype="text" id="grid1_cell_32_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="257" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_32_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="258" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_32_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="259" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="260" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="261" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_32_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="262" or_wd="100"></td><td id="grid1_cell_32_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="263" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_33_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="264" or_wd="100"></td><td datatype="text" id="grid1_cell_33_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="265" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_33_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="266" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_33_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="267" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="268" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="269" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_33_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="270" or_wd="100"></td><td id="grid1_cell_33_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="271" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_34_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="272" or_wd="100"></td><td datatype="text" id="grid1_cell_34_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="273" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_34_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="274" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_34_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="275" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="276" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="277" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_34_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="278" or_wd="100"></td><td id="grid1_cell_34_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="279" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_35_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="280" or_wd="100"></td><td datatype="text" id="grid1_cell_35_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="281" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_35_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="282" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_35_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="283" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="284" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="285" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_35_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="286" or_wd="100"></td><td id="grid1_cell_35_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="287" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_36_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="288" or_wd="100"></td><td datatype="text" id="grid1_cell_36_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="289" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_36_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="290" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_36_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="291" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="292" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="293" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_36_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="294" or_wd="100"></td><td id="grid1_cell_36_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="295" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_37_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="296" or_wd="100"></td><td datatype="text" id="grid1_cell_37_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="297" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_37_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="298" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_37_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="299" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="300" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="301" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_37_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="302" or_wd="100"></td><td id="grid1_cell_37_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="303" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_38_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="304" or_wd="100"></td><td datatype="text" id="grid1_cell_38_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="305" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_38_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="306" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_38_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="307" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="308" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="309" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_38_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="310" or_wd="100"></td><td id="grid1_cell_38_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="311" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_39_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="312" or_wd="100"></td><td datatype="text" id="grid1_cell_39_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="313" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_39_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="314" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_39_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="315" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="316" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="317" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_39_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="318" or_wd="100"></td><td id="grid1_cell_39_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="319" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_40_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="320" or_wd="100"></td><td datatype="text" id="grid1_cell_40_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="321" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_40_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="322" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_40_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="323" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="324" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="325" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_40_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="326" or_wd="100"></td><td id="grid1_cell_40_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="327" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_41_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="328" or_wd="100"></td><td datatype="text" id="grid1_cell_41_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="329" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_41_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="330" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_41_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="331" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="332" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="333" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_41_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="334" or_wd="100"></td><td id="grid1_cell_41_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="335" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_42_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="336" or_wd="100"></td><td datatype="text" id="grid1_cell_42_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="337" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_42_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="338" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_42_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="339" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="340" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="341" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_42_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="342" or_wd="100"></td><td id="grid1_cell_42_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="343" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_43_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="344" or_wd="100"></td><td datatype="text" id="grid1_cell_43_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="345" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_43_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="346" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_43_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="347" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="348" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="349" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_43_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="350" or_wd="100"></td><td id="grid1_cell_43_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="351" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_44_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="352" or_wd="100"></td><td datatype="text" id="grid1_cell_44_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="353" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_44_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="354" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_44_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="355" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="356" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="357" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_44_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="358" or_wd="100"></td><td id="grid1_cell_44_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="359" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_45_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="360" or_wd="100"></td><td datatype="text" id="grid1_cell_45_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="361" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_45_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="362" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_45_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="363" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="364" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="365" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_45_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="366" or_wd="100"></td><td id="grid1_cell_45_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="367" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_46_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="368" or_wd="100"></td><td datatype="text" id="grid1_cell_46_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="369" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_46_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="370" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_46_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="371" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="372" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="373" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_46_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="374" or_wd="100"></td><td id="grid1_cell_46_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="375" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_47_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="376" or_wd="100"></td><td datatype="text" id="grid1_cell_47_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="377" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_47_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="378" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_47_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="379" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="380" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="381" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_47_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="382" or_wd="100"></td><td id="grid1_cell_47_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="383" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_48_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="384" or_wd="100"></td><td datatype="text" id="grid1_cell_48_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="385" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_48_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="386" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_48_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="387" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="388" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="389" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_48_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="390" or_wd="100"></td><td id="grid1_cell_48_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="391" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_49_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="392" or_wd="100"></td><td datatype="text" id="grid1_cell_49_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="393" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_49_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="394" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_49_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="395" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="396" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="397" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_49_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="398" or_wd="100"></td><td id="grid1_cell_49_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="399" or_wd="50"></td></tr></tbody>